Peter Bouwman
Impact in
- Oncology top 2%
- PARP inhibition in cancer therapy
- Molecular Biology top 2%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Sphingolipid Metabolism and Signaling
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- RNA Research and Splicing
Papers in
-
- DNA Repair Mechanisms 15
- CRISPR and Genetic Engineering 10
- RNA modifications and cancer 3
- Genomics and Chromatin Dynamics 3
- Epigenetics and DNA Methylation 3
- Genetics 14
- BRCA gene mutations in cancer 11
- Co-authors
- Jos Jonkers (23 shared papers)Sjaak Philipsen (4 shared papers)Christine L. Mummery (2 shared papers)Sven Rottenberg (4 shared papers)Wouter H. Moolenaar (1 shared paper)Michael J.O. Wakelam (1 shared paper)Laurens A. van Meeteren (1 shared paper)Jean Sébastien Saulnier‐Blache (1 shared paper)
- Journals
- Clinical Cancer Research (3 papers)The Journal of Pathology (3 papers)Nature Communications (2 papers)Genes & Development (2 papers)The EMBO Journal (2 papers)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
Peter Bouwman
40 papers receiving 3.3k citations
Peter Bouwman's Hit Papers
Peers
Comparison fields: 5 of 112
- Oncology 1.1k
- Molecular Biology 2.5k
- Cancer Research 400
- Immunology 424
- Cell Biology 319
Countries citing papers authored by Peter Bouwman
This map shows the geographic impact of Peter Bouwman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bouwman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bouwman more than expected).
Fields of papers citing papers by Peter Bouwman
This network shows the impact of papers produced by Peter Bouwman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bouwman. The network helps show where Peter Bouwman may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Bouwman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance Hit paper breakdown → | 2012 | 498 |
| 2 | PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer Hit paper breakdown → | 2019 | 476 |
| 3 | 2006 | 448 | |
| 4 | 2002 | 394 | |
| 5 | 2011 | 197 | |
| 6 | 2000 | 166 | |
| 7 | 2010 | 130 | |
| 8 | 2004 | 127 | |
| 9 | 2013 | 118 | |
| 10 | 2013 | 92 | |
| 11 | 2017 | 87 | |
| 12 | 1994 | 78 | |
| 13 | 2009 | 66 | |
| 14 | 2013 | 52 | |
| 15 | 2001 | 50 | |
| 16 | 2003 | 39 | |
| 17 | 2018 | 36 | |
| 18 | 2013 | 35 | |
| 19 | 2020 | 32 | |
| 20 | 2012 | 30 |
About Peter Bouwman
Peter Bouwman is a scholar working on Molecular Biology, Genetics, Oncology, Cell Biology and Physiology, having authored 42 papers that have together received 3.4k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (15 papers), BRCA gene mutations in cancer (11 papers), CRISPR and Genetic Engineering (10 papers), PARP inhibition in cancer therapy (9 papers), Telomeres, Telomerase, and Senescence (3 papers), RNA modifications and cancer (3 papers), Genomics and Chromatin Dynamics (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Oncology (1.1k citations), Molecular Biology (2.5k citations), Cancer Research (400 citations), Immunology (424 citations) and Cell Biology (319 citations). Peter Bouwman has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Jos Jonkers, Sjaak Philipsen, Christine L. Mummery, Sven Rottenberg, Wouter H. Moolenaar, Michael J.O. Wakelam, Laurens A. van Meeteren, Jean Sébastien Saulnier‐Blache, Catelijne Stortelers and Marga A. van Rooijen. Their work appears in journals such as Clinical Cancer Research, The Journal of Pathology, Nature Communications, Genes & Development and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.